Fig 2: Correlation of INHBB expression and (A) chemokines/chemokine receptors, (B) immunoinhibitors, (C) immunostimulators.

Fig 3: The expression of INHBB in (A) GC tissues and normal tissues data from TCGA, (B) GC tissues and paired paracarcinoma tissues data from TCGA, (C) GC tissues and normal tissues data from TCGA and GTEx, (D,E) GC tissues and normal tissues data from GSE29272 and GSE26899, and the association between INHBB expression and (F) DSS event, (G) PFI event, (H) histological type, (I) OS event.

Fig 4: Functional enrichment of INHBB in GC. (A)GO enrichment analysis of INHBB in GC, (B) KEGG pathway analysis of INHBB in GC, and (C) GSEA enrichment analysis of INHBB in GC.

Fig 5: The epigenetic changes of INHBB in GC. (A) Genetic alteration of INHBB in GC, (B) Correlation of methylation and INHBB expression in GC.